Commentary: IL-17 in Chronic Inflammation: From Discovery to Targeting.

about

Commentary: IL-17 in Chronic Inflammation: From Discovery to Targeting.

Item

http://www.wikidata.org/entity/Q42365039

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Commentary: IL-17 in Chronic Inflammation: From Discovery to Targeting.

@en

Commentary: IL-17 in Chronic Inflammation: From Discovery to Targeting.

@nl

type

Item

label

Commentary: IL-17 in Chronic Inflammation: From Discovery to Targeting.

@en

Commentary: IL-17 in Chronic Inflammation: From Discovery to Targeting.

@nl

prefLabel

Commentary: IL-17 in Chronic Inflammation: From Discovery to Targeting.

@en

Commentary: IL-17 in Chronic Inflammation: From Discovery to Targeting.

@nl

P1476

Commentary: IL-17 in Chronic Inflammation: From Discovery to Targeting.

@en

P2093

Francesco Maione

http://www.w3.org/2001/XMLSchema#string

P2860

Herpesvirus Saimiri encodes a new cytokine, IL-17, which binds to a novel cytokine receptor

IL-17A facilitates platelet function through the ERK2 signaling pathway in patients with acute coronary syndrome

IL-17 in Chronic Inflammation: From Discovery to Targeting.

IL-17A increases ADP-induced platelet aggregation.

From IL-15 to IL-33: the never-ending list of new players in inflammation. Is it time to forget the humble aspirin and move ahead?

Autoimmune myopathies: autoantibodies, phenotypes and pathogenesis.

Biomarkers for cardiovascular risk assessment in autoimmune diseases.

Critical Link Between Epigenetics and Transcription Factors in the Induction of Autoimmunity: a Comprehensive Review.

Interleukin-17A Exacerbates Ferric Chloride-Induced Arterial Thrombosis in Rat Carotid Artery.

Simvastatin inhibits the pro-inflammatory and pro-thrombotic effects of IL-17 and TNF-α on endothelial cells.

P304

250

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3389/FPHAR.2016.00250

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-08-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27561214

http://www.w3.org/2001/XMLSchema#string

P932

4980561

http://www.w3.org/2001/XMLSchema#string